Stanford University
Showing 101-150 of 165 Results
-
Janice Lin
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Lin specializes in the diagnosis and treatment of rheumatologic conditions such as rheumatoid arthritis, lupus, myositis, gout, and seronegative spondyloarthropathies. She received additional training in autoimmune skin diseases and has a special clinical and research interest for psoriasis/psoriatic arthritis, dermatomyositis, cutaneous lupus/systemic lupus. She leads a combined rheumatology-dermatology clinic with Dr. Matthew Lewis in the dermatology department to take care patients collaboratively. Dr. Lin is a graduate of USSONAR (Ultrasound School of North American Rheumatologists) program and performs diagnostic musculoskeletal ultrasound evaluation and interventions. In addition to her clinical work, she leads the quality improvement effort for the division and her most recent projects are focused on patient-reported outcome in rheumatoid arthritis and vaccinations for patients in the rheumatology clinic.
-
Steven Lin
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsArtificial intelligence and machine learning in healthcare
Primary care and population health
Value added medical education -
Brian Linde, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Linde is a double board-certified, fellowship-trained internal medicine doctor with the Department of Medicine, Division of Primary Care & Population Health at Stanford University School of Medicine. He is board certified in both internal medicine and occupational and environmental medicine. He is fellowship trained in occupational and environmental medicine.
Dr. Linde specializes in preventing, managing, and treating work-related injuries and diseases. He uses his expertise to improve the physical and mental wellness of his patients while reducing their exposure to occupational and environmental hazards. As a public health expert, Dr. Linde also focuses on enhancing the health of entire populations through strategies and policies that benefit communities as a whole.
His academic interests include inhalational exposures and occupational lung diseases. During the COVID-19 pandemic, Dr. Linde studied how to increase adherence to infection prevention recommendations in clinical settings. He has also worked on guidance related to exposure to per- and polyfluoroalkyl substances (PFAS). These chemicals, which are found in water, food, and fabrics, are an ongoing public health concern. Dr. Linde has also researched how to improve the mental and physical health of medical students and ways to prevent physician burnout.
Dr. Linde has published in many peer-reviewed journals, including Current Opinion in Pulmonary Medicine and Academic Medicine. As a member of the Committee on the Guidance on PFAS Testing and Health Outcomes, Dr. Linde contributed to Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, a publication of the National Academies of Sciences, Engineering, and Medicine. He was also a reviewer for Archives of Environmental & Occupational Health and the American Journal of Industrial Medicine.
He has written book chapters for Modern Occupational Diseases: Diagnosis, Epidemiology, Management and Prevention and Patty’s Industrial Hygiene. He wrote about preventing occupational and environmental pulmonary disorders for the Merck Manuals Professional Edition. Dr. Linde has been invited to speak at workshops and presentations all over the nation about a range of topics, including environmental health risks in underserved communities and the health effects of floods.
Dr. Linde is a member of the American Board of Internal Medicine and the American Board of Preventive Medicine. He is also a member of the American College of Physicians and the American College of Occupational and Environmental Medicine. -
Malene Lindholm
Instructor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsInterested in the genetics of human performance and the multi-omic response to exercise and training for optimizing human health.
-
Evelyn Bin Ling
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsMy current research interests are in clinical trials related to COVID19 and hospitalized patients.
-
Eleni Linos, MD, MPH, DrPH
Associate Dean for Research, Ben Davenport and Lucy Zhang Professor of Medicine, Professor, of Medicine (Center for Digital Health) and, by courtesy, of Epidemiology and Population Health
BioEleni Linos MD, MPH, DrPH, is the Director of the Stanford Center for Digital Health. She is a Professor of Dermatology and Epidemiology at Stanford University. Dr. Linos also serves as an Associate Dean for Research, leading the KL2 Research Training Program.
Dr. Linos' research focuses on the use of technology in health, dermatology, public health, cancer prevention and the care of older adults. She is dually trained in epidemiology and dermatology and is the principal investigator of several NIH funded studies aimed at improving the lives of patients. She received her medical degree from Cambridge and Oxford universities in the UK, received a masters and doctoral degree from the Harvard School of Public Health and completed her residency at Stanford. -
Anne Liu
Clinical Associate Professor, Pediatrics - Immunology and Allergy
Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.
Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.
One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
of broad-spectrum antibiotics.
She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.
For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.
Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.
Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.
Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.
She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health. -
Christine Kee Liu
Assistant Professor of Medicine (Primary Care and Population Health)
BioDr. Liu and her research program are dedicated to improving the lives of older adults with kidney disease. Currently her research focuses on mobility, which is the ability to move safely and reliably from one place to another. In older adults, poor mobility strongly predicts future disability and death. Retaining mobility has been cited by older adults as fundamental to quality to life; yet many older persons with kidney disease, especially those with late stage chronic kidney disease or outright kidney failure, have trouble just walking across the room or transferring to a chair. Dually trained in geriatric medicine and epidemiology, Dr. Liu also has significant expertise in older adult clinical trials, including safety trials of novel agents as well as intervention studies to reduce infections in older populations.
-
Nathan Lo
Assistant Professor of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsOur research laboratory is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens, both domestically and internationally, including vaccine-preventable infections (including COVID-19) and neglected parasitic diseases (such as schistosomiasis). Our group applies diverse computational methodologies, including tools from fields of epidemiology, mathematical and statistical modeling, simulation, and policy analysis.
A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected parasitic diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health. Nathan served as the lead writer of the World Health Organization guidelines on schistosomiasis (2022) and strongyloidiasis (2024).
Our current research focuses on the following areas:
(1) Vaccine-preventable infectious diseases (including COVID-19) in the United States, with a focus on studying vaccines and transmission dynamics
(2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever
Hiring
We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu. -
TZU HAN LO
Postdoctoral Scholar, Gastroenterology
BioTzu-Han Lo, a researcher at the Institute of Biomedical Sciences at Academia Sinica, has made contributions to the field of macrophage biology. His work has particularly focused on inflammation, especially in the context of fibrotic response. One of his works includes a study on the regulation of macrophage polarization in ureteral obstruction. This research has illuminated the role of inflammatory cell infiltration and activation during the early stages of kidney injury, a common pathological feature of chronic kidney disease.
In addition to his work on macrophage biology, Tzu-Han Lo has also delved into research related to galectins, a family of β-galactoside–binding proteins. His work in this area has centered on the role of galectins in recognizing microbial glycans, particularly lipopolysaccharides (LPSs). He has explored their impact on host defense mechanisms, including autophagy and both canonical and non-canonical inflammasome signaling pathways.
His research has offered insights into the complex interactions between host immunity and microbial components. This has contributed to our understanding of inflammatory responses and their implications for human health. -
Karl Lorenz
Professor of Medicine (Primary Care and Population Health)
BioDr. Karl Lorenz, MD MSHS is a general internal medicine and palliative care physician, and Section chief of the VA Palo Alto-Stanford Palliative Care Program. Formerly at the VA Greater Los Angeles, Dr. Lorenz directed palliative care research at the VA Center for Innovation to Implementation and served on the faculty at the UCLA School of Medicine. Dr. Lorenz is a member of the VA’s national Hospice and Palliative Care Program (HPC) leadership team, director of the operational palliative care Quality Improvement Resource Center (QuIRC), and adjunct facility staff member at RAND. Dr. Lorenz’s work and leadership has been influential to the field of palliative care research. Under Dr. Lorenz’s leadership, since 2009 the Quality Improvement Resource Center (QuIRC) has served as one of three national leadership Centers responsible for strategic and operational support of the VA’s national hospice and palliative care programs. QuIRC develops and implements provider facing electronic tools for the VA’s national electronic medical record to improve the quality of palliative care. In that role, Dr. Lorenz participates with the national leadership team in strategic planning, policy development, and providing resources to support operational efforts. Dr. Lorenz has contributed to the field of global palliative care, serving the World Health Organization in its development of Palliative Care for Older People and leading methods for Palliative Care Essential Medications.
-
Kate Lorig
Professor (Research) of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsCommunity based psycoeducational intervention studies of disease self management for people with chronic diseases. arthritis, lung diseases, heart disease AIDs, low back pain and diabetes. Programs and studies in Spanish and English. Interventions are in small groups, mailed or on the Internet.
-
Anson Lowe
Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Current Research and Scholarly InterestsThe laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.
-
Henry J. Lowe, MD
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy research in the field of biomedical informatics over the past 30 years has focused on the development of novel uses of information technology and computer science to improve human health. My current interests include the Electronic Health Record (EHR), biomedical knowledge representation, Internet applications in healthcare, clinical data warehouses, clinical data and text mining, academic social networking and the use of information technology to support clinical and translational research.
-
Robert Lowsky
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
